A new trading day began on Tuesday, with SpringWorks Therapeutics Inc (NASDAQ: SWTX) stock price up 0.80% from the previous day of trading, before settling in for the closing price of $29.89. SWTX’s price has ranged from $18.00 to $53.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -20.00% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 35.57%. With a float of $66.98 million, this company’s outstanding shares have now reached $73.49 million.
In an organization with 305 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 92.24%, operating margin of -350.12%, and the pretax margin is -328.06%.
SpringWorks Therapeutics Inc (SWTX) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SpringWorks Therapeutics Inc is 9.82%, while institutional ownership is 99.12%. The most recent insider transaction that took place on Sep 03 ’24, was worth 1,988,033. In this transaction Chief Executive Officer of this company sold 49,000 shares at a rate of $40.57, taking the stock ownership to the 1,063,368 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Chief Operating Officer sold 20,000 for $40.65, making the entire transaction worth $812,954. This insider now owns 229,600 shares in total.
SpringWorks Therapeutics Inc (SWTX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 35.57% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Here are SpringWorks Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 25.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.28, a number that is poised to hit -0.75 in the next quarter and is forecasted to reach -1.82 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Let’s dig in a bit further. During the last 5-days, its volume was 0.67 million. That was inferior than the volume of 0.96 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.91%. Additionally, its Average True Range was 1.33.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 12.44%, which indicates a significant decrease from 58.54% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.24% in the past 14 days, which was lower than the 41.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $34.69, while its 200-day Moving Average is $40.76. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $30.43. Second resistance stands at $30.73. The third major resistance level sits at $31.32. If the price goes on to break the first support level at $29.54, it is likely to go to the next support level at $28.95. Assuming the price breaks the second support level, the third support level stands at $28.65.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
With a market capitalization of 2.24 billion, the company has a total of 74,273K Shares Outstanding. Currently, annual sales are 5,450 K while annual income is -325,100 K. The company’s previous quarter sales were 59,730 K while its latest quarter income was -39,920 K.